The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CSF-1R inhibitor, pexidartinib, sensitizes esophageal cancer to PD-1 immune checkpoint blockade in a rat model.
 
Michael Paskewicz
No Relationships to Disclose
 
Ashten Omstead
No Relationships to Disclose
 
Ping Zheng
No Relationships to Disclose
 
Anastasia Gorbunova
No Relationships to Disclose
 
Madison Salvitti
No Relationships to Disclose
 
Adam Alleyne
No Relationships to Disclose
 
Payton Reed
No Relationships to Disclose
 
Sydne Ballengee
No Relationships to Disclose
 
Nabeela Islam
No Relationships to Disclose
 
Blair A. Jobe
No Relationships to Disclose
 
Ronan Joseph Kelly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Lilly; Medscape; Merck; Novartis; Onc Live; Peerview; Pieris Pharmaceuticals; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Ali Hussainy Zaidi
No Relationships to Disclose